Literature DB >> 15588717

Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).

Je-Tae Woo1, Hiroshi Nakagawa, Annette M Krecic, Kazuo Nagai, Andrew D Hamilton, Said M Sebti, Paula H Stern.   

Abstract

We have previously reported that the statin mevastatin (compactin) reversibly inhibits the fusion of TRAP-positive mononuclear preosteoclasts (pOCs) into multinucleated osteoclasts and disrupts the actin ring in mature osteoclasts through the inhibition of protein prenylation. Protein geranylgeranylation, specifically, is known to be required for pOC fusion and for the function and survival of mature osteoclasts. However, it has not been determined whether protein geranylgeranylation is involved in early differentiation of osteoclasts (pOC formation). The current study shows that statins and the geranylgeranyl transferase I inhibitor GGTI-2166 inhibit the pOC formation induced by RANKL or TNF-alpha in cultures of both mouse marrow-derived macrophage-colony-stimulating factor (M-CSF) dependent monocytes (MD cells) and the mouse monocyte cell line RAW 264.7 (RAW cells). Mevastatin, 0.1-0.6 microM, inhibited the formation of pOCs induced by receptor activator of nuclear factor-kappaB ligand (RANKL) or tumor necrosis factor (TNF-alpha) in both cell cultures. The inhibitory effects of mevastatin were overcome by the addition of mevalonate, farnesyl pyrophosphate or geranylgeranyl pyrophosphate. GGTI-2166 inhibited TRAP activity induced by RANKL or TNF-alpha in both cell cultures and prevented the incorporation of [3H]all-trans geranylgeraniol into prenylated proteins in RAW cells. However, the farnesyl transferase inhibitor FTI-2153 did not inhibit TRAP activity although FTI prevented the incorporation of [14C]mevalonate into farnesylated proteins in RAW cells. Clostridium difficile cytotoxin B (toxin B) inhibited pOC formation induced by RANKL or TNF-alpha in both cell cultures. The inhibitory effects of statins and GGTI-2166 on pOC formation may result from the inhibition of the geranylgeranylation of G-proteins, such as Rho or Rac, suggesting that the geranylgeranylation of these proteins is involved in the early differentiation of progenitor cells into pOCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15588717     DOI: 10.1016/j.bcp.2004.08.036

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.

Authors:  Thangaiah Subramanian; Suxia Liu; Jerry M Troutman; Douglas A Andres; H Peter Spielmann
Journal:  Chembiochem       Date:  2008-11-24       Impact factor: 3.164

2.  Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.

Authors:  Mari Okayasu; Mai Nakayachi; Chiyomi Hayashida; Junta Ito; Toshio Kaneda; Masaaki Masuhara; Naoto Suda; Takuya Sato; Yoshiyuki Hakeda
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

3.  Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasis.

Authors:  Subhamoy Dasgupta; Ian Cushman; Marilyne Kpetemey; Patrick J Casey; Jamboor K Vishwanatha
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

Review 4.  Approaches of targeting Rho GTPases in cancer drug discovery.

Authors:  Yuan Lin; Yi Zheng
Journal:  Expert Opin Drug Discov       Date:  2015-06-18       Impact factor: 6.098

5.  Characterization of dystrophic calcification induced in mice by cardiotoxin.

Authors:  Yongdong Zhao; Annette L Urganus; Lyudmila Spevak; Sheela Shrestha; Stephen B Doty; Adele L Boskey; Lauren M Pachman
Journal:  Calcif Tissue Int       Date:  2009-08-20       Impact factor: 4.333

6.  Lovastatin release from polycaprolactone coated β-tricalcium phosphate: effects of pH, concentration and drug-polymer interactions.

Authors:  Solaiman Tarafder; Kelly Nansen; Susmita Bose
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-03-14       Impact factor: 7.328

7.  In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I.

Authors:  Jie Lu; Lai Chan; Hannah D G Fiji; Russell Dahl; Ohyun Kwon; Fuyuhiko Tamanoi
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

Review 8.  Regulation of Small GTPase Prenylation in the Nervous System.

Authors:  Jairus M Reddy; Namrata G R Raut; Jennifer L Seifert; DiAnna L Hynds
Journal:  Mol Neurobiol       Date:  2020-01-27       Impact factor: 5.590

9.  Validity of SW982 synovial cell line for studying the drugs against rheumatoid arthritis in fluvastatin-induced apoptosis signaling model.

Authors:  Jae-Ho Chang; Kyu-Jae Lee; Soo-Ki Kim; Dae-Hyun Yoo; Tae-Young Kang
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

10.  Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells' osteogenic differentiation.

Authors:  I-Chun Tai; Yao-Hsien Wang; Chung-Hwan Chen; Shu-Chun Chuang; Je-Ken Chang; Mei-Ling Ho
Journal:  Int J Nanomedicine       Date:  2015-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.